Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction treatment followed by immunosuppression withdrawal in liver transplantation
2005-005635-10Phase 3Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Mar 2006
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of ATeGe in liver transplant (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Feasibility of tacrolimus minimization at 1 year. Started Mar 2006; status: active.
02
Drugs
ATeGe
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2005-005635-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005635-10.